General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trial

Figures & data

Fig. 1 Study flowchart

Fig. 2 Flowchart of patient flows from invited to participate to completion of end of study questionnaires

Table 1 Patient characteristics at baseline

Fig. 3 Sub-categories of medication-related problems identified at baseline and third assessment in patients (n = 118) who received three pharmacist interventions

Table 2 Medication appropriateness index (MAI) scores; ITT analysis

Fig. 4 Frequency of inappropriate MAI criteria (n = 63 intervention patients; intention-to-treat group)

Table 3 Healthcare resource utilisation in control and intervention group patients at baseline and at 6-month follow-up

Table 4 Cost of healthcare resource utilisation in control and intervention group patients at baseline and at 6-month follow-up

Availability of data and materials

The data used to support the findings of this study are included in this published article and its supplementary information files.